Similar articles for PMID: 24164262

Year	Number of Results
1953	1
2001	2
2002	5
2003	2
2004	6
2005	8
2006	8
2007	5
2008	7
2009	9
2010	7
2011	6
2012	6
2013	7
2014	3
2015	3
2016	3
2017	6
2018	3
2019	1
2021	2
2022	2
2023	1
2024	0

1

The designer proline-rich antibacterial peptide A3-APO prevents Bacillus anthracis mortality by deactivating bacterial toxins.

Otvos L Jr, Flick-Smith H, Fox M, Ostorhazi E, Dawson RM, Wade JD. Otvos L Jr, et al. Protein Pept Lett. 2014 Apr;21(4):374-81. doi: 10.2174/09298665113206660108. Protein Pept Lett. 2014. PMID: 24164262

2

The antibacterial effect of a proline-rich antibacterial peptide A3-APO.

Rozgonyi F, Szabo D, Kocsis B, Ostorházi E, Abbadessa G, Cassone M, Wade JD, Otvos L Jr. Rozgonyi F, et al. Curr Med Chem. 2009;16(30):3996-4002. doi: 10.2174/092986709789352295. Curr Med Chem. 2009. PMID: 19747127 Review.

3

The NheA component of the non-hemolytic enterotoxin of Bacillus cereus is produced by Bacillus anthracis but is not required for virulence.

Mendelson I, Tobery S, Scorpio A, Bozue J, Shafferman A, Friedlander AM. Mendelson I, et al. Microb Pathog. 2004 Sep;37(3):149-54. doi: 10.1016/j.micpath.2004.06.008. Microb Pathog. 2004. PMID: 15351038

4

Peptide inhibitors MAP the way towards fighting anthrax pathogenesis.

DeCathelineau AM, Bokoch GM. DeCathelineau AM, et al. Biochem J. 2006 Apr 1;395(1):e1-3. doi: 10.1042/bj20060245. Biochem J. 2006. PMID: 16541485 Free PMC article.

5

Scope and limitations of the designer proline-rich antibacterial peptide dimer, A3-APO, alone or in synergy with conventional antibiotics.

Cassone M, Vogiatzi P, La Montagna R, De Olivier Inacio V, Cudic P, Wade JD, Otvos L Jr. Cassone M, et al. Peptides. 2008 Nov;29(11):1878-86. doi: 10.1016/j.peptides.2008.07.016. Epub 2008 Aug 5. Peptides. 2008. PMID: 18721837

6

Anthrax X-rayed: new opportunities for biodefence.

Stubbs MT. Stubbs MT. Trends Pharmacol Sci. 2002 Dec;23(12):539-41. doi: 10.1016/s0165-6147(02)02127-2. Trends Pharmacol Sci. 2002. PMID: 12457764 Review.

7

The designer proline-rich antibacterial peptide A3-APO is effective against systemic Escherichia coli infections in different mouse models.

Szabo D, Ostorhazi E, Binas A, Rozgonyi F, Kocsis B, Cassone M, Wade JD, Nolte O, Otvos L Jr. Szabo D, et al. Int J Antimicrob Agents. 2010 Apr;35(4):357-61. doi: 10.1016/j.ijantimicag.2009.10.015. Epub 2009 Dec 23. Int J Antimicrob Agents. 2010. PMID: 20031377

8

The Fluorocycline TP-271 Is Efficacious in Models of Aerosolized Bacillus anthracis Infection in BALB/c Mice and Cynomolgus Macaques.

Grossman TH, Anderson MS, Drabek L, Gooldy M, Heine HS, Henning LN, Lin W, Newman JV, Nevarez R, Siefkas-Patterson K, Radcliff AK, Sutcliffe JA. Grossman TH, et al. Antimicrob Agents Chemother. 2017 Sep 22;61(10):e01103-17. doi: 10.1128/AAC.01103-17. Print 2017 Oct. Antimicrob Agents Chemother. 2017. PMID: 28784679 Free PMC article.

9

Small-molecule inhibitors of lethal factor protease activity protect against anthrax infection.

Moayeri M, Crown D, Jiao GS, Kim S, Johnson A, Leysath C, Leppla SH. Moayeri M, et al. Antimicrob Agents Chemother. 2013 Sep;57(9):4139-45. doi: 10.1128/AAC.00941-13. Epub 2013 Jun 17. Antimicrob Agents Chemother. 2013. PMID: 23774434 Free PMC article.

10

Peptide conjugated phosphorodiamidate morpholino oligomers increase survival of mice challenged with Ames Bacillus anthracis.

Panchal RG, Geller BL, Mellbye B, Lane D, Iversen PL, Bavari S. Panchal RG, et al. Nucleic Acid Ther. 2012 Oct;22(5):316-22. doi: 10.1089/nat.2012.0362. Epub 2012 Sep 14. Nucleic Acid Ther. 2012. PMID: 22978365 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

96 results

Results by year